Evidence map›Paper›PMID 29114248›Full record

ArticleFrontiers in immunology2017

Intramuscular DNA Vaccination of Juvenile Carp against Spring Viremia of Carp Virus Induces Full Protection and Establishes a Virus-Specific B and T Cell Response.

Carmen W E Embregts, Dimitri Rigaudeau, Tomáš Veselý, Dagmar Pokorová, Niels Lorenzen, Jules Petit, Armel Houel, Malte Dauber, Heike Schütze, Pierre Boudinot and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CyanobacteriaToxins · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. A DNA Vaccine Encoding the VAA Gene ofFrontiers in immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Carmen W E EmbregtsCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University, Wageningen, Netherlands.
Dimitri RigaudeauINRA, Infectiologie Expérimentale Rongeurs Poissons, Université Paris-Saclay, Jouy-en-Josas, France.
Tomáš VeselýVeterinary Research Institute, Brno, Czechia.
Dagmar PokorováVeterinary Research Institute, Brno, Czechia.
Niels LorenzenNational Veterinary Institute, DTU, Lyngby, Denmark.
Jules PetitCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University, Wageningen, Netherlands.
Armel HouelINRA, Virologie et Immunologie Moléculaires, Université Paris-Saclay, Jouy-en-Josas, France.
Malte DauberFriedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute for Infectiology, Insel Riems, Germany.
Heike SchützeFriedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute for Infectiology, Insel Riems, Germany.
Pierre BoudinotINRA, Virologie et Immunologie Moléculaires, Université Paris-Saclay, Jouy-en-Josas, France.
Geert F WiegertjesCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University, Wageningen, Netherlands.
Maria ForlenzaCell Biology and Immunology Group, Department of Animal Sciences, Wageningen University, Wageningen, Netherlands.
Wageningen University & Research · NLFriedrich-Loeffler-Institut · DEVeterinary Research Institute · CZVirologie et Immunologie Moléculaires · FRDelft University of Technology · NLUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although spring viremia of carp virus (SVCV) can cause high mortalities in common carp, a commercial vaccine is not available for worldwide use. Here, we report a DNA vaccine based on the expression of the SVCV glycoprotein (G) which, when injected in the muscle even at a single low dose of 0.1 µg DNA/g of fish, confers up to 100% protection against a subsequent bath challenge with SVCV. Importantly, to best validate vaccine efficacy, we also optimized a reliable bath challenge model closely mimicking a natural infection, based on a prolonged exposure of carp to SVCV at 15°C. Using this optimized bath challenge, we showed a strong age-dependent susceptibility of carp to SVCV, with high susceptibility at young age (3 months) and a full resistance at 9 months. We visualized local expression of the G protein and associated early inflammatory response by immunohistochemistry and described changes in the gene expression of pro-inflammatory cytokines, chemokines, and antiviral genes in the muscle of vaccinated fish. Adaptive immune responses were investigated by analyzing neutralizing titers against SVCV in the serum of vaccinated fish and the

Indexed as

B cellsDNA vaccinationrhabdovirusspring viremia of carp virusT cells

Identifiers

PMID29114248
PMCPMC5660689
OpenAlexW2766992632

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.